544 related articles for article (PubMed ID: 19222433)
21. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
22. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
23. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
24. Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex.
Staals LM; Driessen JJ; Van Egmond J; De Boer HD; Klimek M; Flockton EA; Snoeck MM
Acta Anaesthesiol Scand; 2011 Jul; 55(6):700-7. PubMed ID: 21574968
[TBL] [Abstract][Full Text] [Related]
25. In vivo animal studies with sugammadex.
Booij LH; van Egmond J; Driessen JJ; de Boer HD
Anaesthesia; 2009 Mar; 64 Suppl 1():38-44. PubMed ID: 19222430
[TBL] [Abstract][Full Text] [Related]
26. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
27. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
[TBL] [Abstract][Full Text] [Related]
29. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.
Ren WH; Jahr JS
Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969
[TBL] [Abstract][Full Text] [Related]
30. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
Mosing M; Auer U; West E; Jones RS; Hunter JM
Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
Lee C; Katz RL
J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
[TBL] [Abstract][Full Text] [Related]
32. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
[TBL] [Abstract][Full Text] [Related]
33. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
[TBL] [Abstract][Full Text] [Related]
34. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
[TBL] [Abstract][Full Text] [Related]
35. Sugammadex: A Review of Neuromuscular Blockade Reversal.
Keating GM
Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
[TBL] [Abstract][Full Text] [Related]
36. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.
Staals LM; Snoeck MM; Driessen JJ; Flockton EA; Heeringa M; Hunter JM
Br J Anaesth; 2008 Oct; 101(4):492-7. PubMed ID: 18653492
[TBL] [Abstract][Full Text] [Related]
37. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
[TBL] [Abstract][Full Text] [Related]
38. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
[TBL] [Abstract][Full Text] [Related]
39. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
[TBL] [Abstract][Full Text] [Related]
40. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
